Medical providers evaluate each patient individually because weight management needs differ significantly between people
"Medicare also doesn't approve medications with short-term benefits, low efficacy and risks shouldn't outweigh the benefits." Yu said that ultimately the cost of Wegovy might still put the brakes on Medicare's coverage
doi:10.1056/NEJMoa2301972 Rosenstock J, Frias J, Jastreboff AM, et al
Factors like cycle length , degree of suppression , hepatotoxicity , and cardiovascular impact influence how long you should stay off before your next cycle
Ongoing work continues to investigate its mechanisms, delivery optimisation, and potential applications across sleep science, neuroendocrinology, and stress-related research.
This classification is similar to most countries worldwide, where BPC-157 remains in research chemical status pending completion of human clinical trials